Former Turing Pharmaceuticals CEO Martin Shkreli, left, arrives to federal court with his attorney Benjamin Brafman in New York, Monday, June 26, 2017. Even with his federal securities fraud trial set to begin Monday, Shkreli has blatantly defied his attorneys' advice to lay low. (AP Photo/Seth Wenig)

NEW YORK - The Latest on jury selection at the trial of former pharmaceutical company CEO Martin Shkreli (all times local):

1:50 p.m.

Several potential jurors have told a New York judge they can't be fair toward a former pharmaceutical company CEO who became a pariah after jacking up the cost of a life-saving medication.

One woman said Monday that she knew Martin Shkreli (SHKREHL'-ee) as "the most hated man in America" for his price gouging. The judge dismissed her and several other potential jurors after they made negative comments about Shkreli during jury selection for his securities fraud trial in Brooklyn.

The 34-year-old Shkreli has upended conventional wisdom about avoiding bad pretrial publicity with nonstop boasts and rants on social media.

Shkreli told The Associated Press that he's "excited" about the trial.

Opening statements could begin as early as Tuesday.

___

11 a.m.

A trial has begun for a former pharmaceutical company CEO who became a pariah after raising the cost of a life-saving medication 5,000 per cent.

Before jury selection started Monday at his securities fraud trial, Martin Shkreli (SHKREHL'-ee) hadn't stopped preening for cameras and trolling on social media. Legal experts say the behaviour has upended conventional wisdom about avoiding negative pretrial publicity.

His lawyer claimed last year the 34-year-old Shkreli had agreed to lay low until his case was resolved. But since then, he's gone online to call members of Congress "imbeciles" and mock a freelance journalist in a way that got him kicked off of Twitter.

Shkreli told The Associated Press that he's "excited" about the trial.

Opening statements could begin as early as Tuesday.

___

12:30 a.m.

A former pharmaceutical company CEO who became a pariah after raising the cost of a life-saving medication 5,000 per cent just can't keep quiet.

Even with his securities fraud trial set to begin with jury selection on Monday, Martin Shkreli (SHKREHL'-ee) hasn't stopped preening for cameras and trolling on social media. Legal experts say the behaviour has upended conventional wisdom about avoiding negative pretrial publicity.

His lawyer claimed last year the 34-year-old Shkreli had agreed to lay low until his case was resolved. But since then, he's gone online to call members of Congress "imbeciles" and mock a freelance journalist in a way that got him kicked off of Twitter.

Shkreli told The Associated Press that he's "excited" about the trial.

News from © The Associated Press, 2017